Latest news and articles about أسعار الأدوية from NEX English
U.S. President Donald Trump has announced a new agreement with Regeneron aimed at significantly reducing drug prices in the United States. This announcement comes at a critical time as citizens struggle with rising healthcare costs.
Global drug prices are experiencing a significant increase due to pressures from rising fuel and energy costs, exacerbated by the closure of the Strait of Hormuz. This situation negatively impacts manufacturing costs and supply chains, raising concerns among consumers and affected nations.
The United States is facing a growing crisis in drug prices, necessitating urgent legal measures to limit the powers of pharmacy benefit managers. Legislators must intervene to protect citizens' health and ensure access to essential medications.
Reports indicate that the Trump administration plans to impose new fees on several pharmaceutical companies to reduce drug costs in the U.S. This move comes at a sensitive time as the healthcare system faces increasing pressures.